In vitro inhibition of platelets aggregation with generic form of clopidogrel versus branded in patients with stable angina pectoris

Introduction: Clopidogrel is a potent platelet activation and aggregation inhibitor that prevents thrombosis in coronary artery diseases (CADs). In comparison to locally produced generic one (Osvix®), original brand of clopidogrel (Plavix®) is expensive. This study was designed to evaluate the effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajizadeh, Rza, Ghaffari, Samad, Ziaee, Mojtaba, Shokouhi, Behrooz, Separham, Ahmad, Sarbakhsh, Parvin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787330/
https://www.ncbi.nlm.nih.gov/pubmed/29391931
http://dx.doi.org/10.15171/jcvtr.2017.33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787330/
https://www.ncbi.nlm.nih.gov/pubmed/29391931
http://dx.doi.org/10.15171/jcvtr.2017.33

Ejemplares similares